Strong Synergic Growth Inhibition and Death Induction of Cancer Cells by Astragalus membranaceus and Vaccaria hispanica Extract

Zoya Cohen*, Yair Maimon, Noah Samuels, Hadar Brand, Aaron Sulkes, Baruch Brenner, Raanan Berger

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

We present here a new, classification-based screening method for anti-cancer botanical combinations. Using this method, we discovered that the combination of Astragalus membranaceus and Vaccaria hispanica (AV) has strong synergic anti-proliferative and killing effects on cancer cells. We showed that AV induces the hyper activation of proliferation and survival pathways (Akt and ERK1/2) and strongly downregulates the cell cycle control proteins p21 and p27. Moreover, FACS analyses revealed that AV induces accumulation of cells in G2/M phase, supported by accumulation of cyclin A. Taken together, our results suggest that AV interferes with the cell cycle in cancer cells, leading to accumulation in G2/M and apoptosis. Further studies are needed to validate the generalizability of the anti-cancer effect of the AV combination, to fully understand its mechanism of action and to evaluate its potential as a new anti-cancer treatment.

Original languageEnglish
Article number5833
JournalCancers
Volume14
Issue number23
DOIs
StatePublished - Dec 2022

Keywords

  • anti-cancer
  • botanical extracts
  • cell cycle
  • drug screening
  • synergic drugs

Fingerprint

Dive into the research topics of 'Strong Synergic Growth Inhibition and Death Induction of Cancer Cells by Astragalus membranaceus and Vaccaria hispanica Extract'. Together they form a unique fingerprint.

Cite this